Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients 2022-02-11 20:40
Ucello Therapeutics Completes US$25 Million Series A Financing 2022-02-11 02:16
AKESO'S NGF MONOCLONAL ANTIBODY (AK115) APPROVED TO INITIATE CLINICAL TRIAL IN PAIN (INCLUDING CANCER PAIN) 2022-02-10 17:00
Bijoyesh Mookerjee, M.D. named Chief Medical Officer, Oncology for Simcere Pharmaceuticals 2022-02-08 10:01
Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics 2022-02-08 06:00
US FDA Study May Proceed letter for Clarity's Cu-64 SAR-bisPSMA trial in prostate cancer 2022-02-07 22:08
KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE 2022-02-07 21:00
Samsung Biologics receives 2022 CMO Leadership Award in all six categories 2022-02-07 20:00
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine 2022-02-04 06:54
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good 2022-02-01 21:00
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital 2022-01-29 11:37
CTB001, Bioheng auto CAR - T Product, received Orphan Drug Designation (ODD) from the U.S. FDA 2022-01-28 22:00
I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs 2022-01-28 21:00
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis 2022-01-28 08:10
Ractigen Therapeutics closes an additional $30 million in Series A+ funding to push development of its RNAa platform 2022-01-27 22:10
Adlai Nortye Announces Global License-out Agreement with Biotime for Several Products Including PD-L1 Inhibitor (AN4005) and Anti-hTNFR2 Antibody (AN3025) 2022-01-26 21:00
Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in Androgen Alopecia 2022-01-26 08:00
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by EMA 2022-01-25 22:00
Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug 2022-01-25 22:00
1 85 86 87 88 89 165